-
公开(公告)号:WO2023007499A1
公开(公告)日:2023-02-02
申请号:PCT/IL2022/050823
申请日:2022-07-28
Applicant: IMMUNYX PHARMA LTD. , YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. , HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.
Inventor: SALPETER, Seth Jonah , NAIM, Meital , GRANOT, Zvika , FRIDLENDER, Zvi Gregorio
IPC: A61K31/435 , A61K31/437 , A61K31/495 , A61K31/496 , A61K31/135 , A61K31/137 , A61K31/366 , A61K31/4422 , A61K31/4453 , A61K31/4709 , A61K31/506 , A61K31/519 , A61K9/50 , A61K31/5415 , A61K9/51 , B82Y5/00 , C07D471/04 , C07D471/12 , C07D471/14 , A61P29/00 , A61P35/00
Abstract: Methods of inhibiting reactive oxygen species production by neutrophils or treating neutrophil-mediated inflammation in a subject by contacting the neutrophils with or administering an agent selected from a cyclin dependent kinase 4 (CDK4) inhibitor, a cyclin dependent kinase 6 (CDK6) inhibitor, an epidermal growth factor receptor (EGFR) inhibitor, a proto-oncogene tyrosine-protein kinase Src (SRC) inhibitor and a sodium (Na) channel blocker are provided. Pharmaceutical compositions comprising a nanoparticle, the agent and a neutrophil targeting peptide are also provided.
-
公开(公告)号:WO2022264124A2
公开(公告)日:2022-12-22
申请号:PCT/IL2022/050622
申请日:2022-06-12
Inventor: BENNY, Ofra , AMOYAV, Ben Zion
IPC: A61K9/16 , A61K31/135 , A61K31/704 , A61K49/04 , A61K9/50 , A61K9/00 , A61K31/13 , A61K31/70 , A61K9/19 , A61K31/136 , A61K31/407 , A61K31/53 , A61K49/048 , A61K9/0019 , A61K9/1635 , A61K9/1641 , A61K9/1647 , A61K9/5031 , A61K9/5036 , A61K9/5052 , A61K9/5057 , A61K9/5089 , A61L24/001 , A61L24/0015 , A61L24/0036 , A61L24/04 , A61L24/046 , A61L2400/12 , A61L2430/36 , A61P35/00
Abstract: The invention provides a novel class of microparticles suitable for inducing or causing embolism to blood microvessels.
-
公开(公告)号:WO2022249182A2
公开(公告)日:2022-12-01
申请号:PCT/IL2022/050555
申请日:2022-05-25
Inventor: AMAL, Haitham
IPC: G01N33/68 , G01N33/497 , G16H50/70 , G01N2440/14 , G01N2440/26 , G01N33/6896 , G16B25/10 , G16H50/20
Abstract: The present invention is directed to methods for determining an autism spectrum condition in a subject. The methods comprise determining in a sample obtained from the subject any one of: (i) an elevated expression level of at least one biomarker selected from Table 2; (ii) a reduced expression level of at least one biomarker selected from Table 3; (iii) phosphorylation of at least one biomarker selected from Table 4; (iv) S-nitrosylation (SNO) of at least one biomarker selected from Table 5; (v) a volatile organic compound (VOC) profile comprising at least one VOC selected from any one of Table la, Table lb, Table lc, Table Id, Table le, (vi) any combination of (i) to (v), wherein a significant change of the at least one biomarker in said sample compared to control, is indicative of the subject being afflicted with an autism spectrum condition. Further provided is a kit suitable for determining an autism spectrum condition.
-
公开(公告)号:WO2022239007A1
公开(公告)日:2022-11-17
申请号:PCT/IL2022/050495
申请日:2022-05-12
Inventor: ETGAR, Lioz , MAGDASSI, Shlomo , KUMAR, Pendyala Naresh
IPC: H01L51/00 , H01L51/42 , H01L51/44 , H01L51/0005 , H01L51/4226
Abstract: The technology generally concerns perovskite-based devices having improved transparency and uses thereof.
-
公开(公告)号:WO2022234588A1
公开(公告)日:2022-11-10
申请号:PCT/IL2022/050719
申请日:2022-07-05
Inventor: LEVY, Uriel , EDREI, Eitan
Abstract: The disclosure relates to the technique, including systems and methods, for use in optical topographical and/or tomographic 3D imaging of a sample. The system may include (a) a lens unit, chromatically dispersive so that its focal length varies depending on a light wavelength, the lens unit being configured to pass therethrough polychromatic light arriving from and originated at a sample, while selectively collimating those spectral components of the polychromatic light which are in focus based on their wavelengths and origins; and (b) an etalon structure accommodated in an optical path of light being output from the lens unit to receive the collimated light, said etalon structure being configured to operate with multiple resonant wavelengths and to provide respective spectral transmittance peaks at said resonant wavelengths.
-
公开(公告)号:WO2022175960A1
公开(公告)日:2022-08-25
申请号:PCT/IL2022/050204
申请日:2022-02-21
Applicant: ICHILOV TECH LTD. , YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
Inventor: BEN BASHAT, Dafna , BEN SIRA, Liat , LINK, Dafna , AVISDRIS, Netanell , JOSKOWICZ, Leo
Abstract: A system and method of predicting a condition of a fetus may include receiving a magnetic resonance imaging (MRI) scan of the fetus, comprising a sequence of slices; detecting a volume of interest (VOI) representing a location of a brain of the fetus; segmenting one or more slices comprised in the VOI to a set of brain structures selected from a right hemisphere, a left hemisphere, a right lateral ventricle, and a left lateral ventricle; based on said segmentation, calculating at least one ventricle; and predicting a condition of the fetus based on the at least one ventricle metric.
-
公开(公告)号:WO2022149144A1
公开(公告)日:2022-07-14
申请号:PCT/IL2022/050035
申请日:2022-01-11
Inventor: BENITA, Simon , NASSAR, Taher
Abstract: The invention generally concerns formulations of cannabinoids for cosmetic purposes. To that end, the invention provides formulations with improved stability and topical delivery, as well as improved efficacy in terms of anti-inflammatory, anti-aging effects, and skin protective effects overall.
-
公开(公告)号:WO2022123569A1
公开(公告)日:2022-06-16
申请号:PCT/IL2021/051465
申请日:2021-12-09
Inventor: COHN, Daniel , ELYASHIV, Ariel , KHALAILA, Abir , SLOUTSKI, Aaron
Abstract: The technology concerns a construct comprising at least one tissular region and at least one polymeric region for use as an implant.
-
公开(公告)号:WO2022107144A1
公开(公告)日:2022-05-27
申请号:PCT/IL2021/051381
申请日:2021-11-18
Applicant: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. , THE PENN STATE RESEARCH FOUNDATION
Inventor: SPIEGELMAN, Vladimir , SINGH, Vikash , SHARMA, Arun , SINGH, Amandeep , YISRAELI, Joel , WALLIS, Nadav , OBERMAN, Froma
IPC: C07D403/10 , C07D407/04 , C07D407/12 , C07D407/14 , C07D413/14 , A61K31/44 , A61K31/496 , A61K31/498 , A61K31/5355 , A61P35/00
Abstract: The present invention is directed to compounds and compositions comprising thereof. Further, methods of use such as for the treatment and prevention of a disorder associated with binding of IGF2BP1 to an RNA in a subject in need thereof are also provided.
-
公开(公告)号:WO2022091105A1
公开(公告)日:2022-05-05
申请号:PCT/IL2021/051299
申请日:2021-11-02
Inventor: YERUSHALMI, Roie
IPC: C01B32/168 , C01B32/00 , C01B32/156 , C01B32/194 , C01B32/198 , C01B32/21 , C01B32/28 , C09C1/48 , D01F1/00
Abstract: The invention concerns a composite material comprising a carbon-based material and a non-continuous film comprising a plurality of regions of a metal-based wetting material associated with the carbon-based material, the non-continuous film of the wetting material being configured to tune the carbon-based material to adhesively receive thereon a film of at least one polymeric material.
-
-
-
-
-
-
-
-
-